Release Date: 10/04/2022
Expiration Date: 10/04/2023
Learner Notification
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Speakers
Molly K. Stott, PharmD
Emergency Medicine and Clinical Toxicology Fellow
FL/USVI Poison Information Center
Has disclosed no relevant financial relationships
Moderator
Nicholas Nacca, MD
Assistant Professor, Emergency Medicine
University of Rochester Medical Center
Has disclosed no relevant financial relationships
Organizer
Shawn M. Varney, MD, FAACT, FACEP, FACMT
Professor of Emergency Medicine
Medical Director, South Texas Poison Center
University of Texas Health Science Center San Antonio
Has disclosed no relevant financial relationships
Description
This webinar will provide the opportunity for toxicologists to be presented with the most up-to-date literature and rationale for double dose N-acetylcysteine, use of fomepizole as an adjunct therapy,and when to consider hemodialysis in massive acetaminophen overdose. Additionally, it will allow for toxicologists to make a well-informed decision whether to include increased dosing of N-acetylcysteine and/or fomepizole in their management of massive acetaminophen overdose.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives – After attending this program you should be able to:
- Summarize pathophysiology of acetaminophen (APAP) toxicity.
- Define massive acetaminophen overdose.
- Discuss modified NAC protocols for massive acetaminophen overdose.
- Review emerging adjunctive therapies for massive acetaminophen overdose.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.
Click here to complete the Post Webinar CE Evaluation